WO2003015801A1 - Hemostatic material, complex hemostatic material and method of hemostasis - Google Patents

Hemostatic material, complex hemostatic material and method of hemostasis Download PDF

Info

Publication number
WO2003015801A1
WO2003015801A1 PCT/JP2002/007904 JP0207904W WO03015801A1 WO 2003015801 A1 WO2003015801 A1 WO 2003015801A1 JP 0207904 W JP0207904 W JP 0207904W WO 03015801 A1 WO03015801 A1 WO 03015801A1
Authority
WO
WIPO (PCT)
Prior art keywords
hemostatic material
visible light
bleeding
complex
hemostasis
Prior art date
Application number
PCT/JP2002/007904
Other languages
French (fr)
Japanese (ja)
Inventor
Shinichi Sugihara
Yuichiro Irie
Original Assignee
Ecodevice Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecodevice Corporation filed Critical Ecodevice Corporation
Publication of WO2003015801A1 publication Critical patent/WO2003015801A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Abstract

A hemostatic material which is a semiconductor photocatalyst having a visible light activity and to be located around a bleeding face in a vital tissue and irradiated with rays including visible light to thereby stop the bleeding; a complex hemostatic material which has a layer carrying a semiconductor photocatalyst having a visible light activity on one face of a visible light-permeable support; and a method of hemostasis which comprises locating a hemostatic material comprising a semiconductor photocatalyst having a visible light activity on a bleeding face in an oral tissue, or locating a complex hemostatic material provided with a layer carrying a semiconductor photocatalyst having a visible light activity so that the photocatalyst-carrying layer is in contact with the above-described bleeding face, and then irradiating the hemostatic material or the complex hemostatic material with rays including visible light to thereby stop the bleeding. The hemostatic materials and the hemostasis method show an immediate action without any troubles such as coloration.
PCT/JP2002/007904 2001-08-14 2002-08-02 Hemostatic material, complex hemostatic material and method of hemostasis WO2003015801A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-245919 2001-08-14
JP2001245919 2001-08-14

Publications (1)

Publication Number Publication Date
WO2003015801A1 true WO2003015801A1 (en) 2003-02-27

Family

ID=19075578

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/007904 WO2003015801A1 (en) 2001-08-14 2002-08-02 Hemostatic material, complex hemostatic material and method of hemostasis

Country Status (1)

Country Link
WO (1) WO2003015801A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI613990B (en) * 2016-12-08 2018-02-11 南臺科技大學 Hemostasis method
TWI618525B (en) * 2016-12-13 2018-03-21 奇美醫療財團法人奇美醫院 Femoral artery compression hemostasis device
CN108720885A (en) * 2017-04-20 2018-11-02 南台科技大学 Hemostasis

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09322935A (en) * 1996-06-05 1997-12-16 Tao:Kk Sterilizing patch sheet
JP2000136129A (en) * 1998-10-29 2000-05-16 Yoshitaka Ohashi Sheet
JP2000237230A (en) * 1999-02-17 2000-09-05 Kyoshin Shoji Co Ltd Photocatalyst fixing adhesive tape
JP2001106633A (en) * 1999-08-02 2001-04-17 Kenichi Yamanaka Utilization of titanium oxide as drug or substance analogous to drug
JP2001114693A (en) * 1999-08-09 2001-04-24 Kenichi Yamanaka Therapeutic article using titanium oxide

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09322935A (en) * 1996-06-05 1997-12-16 Tao:Kk Sterilizing patch sheet
JP2000136129A (en) * 1998-10-29 2000-05-16 Yoshitaka Ohashi Sheet
JP2000237230A (en) * 1999-02-17 2000-09-05 Kyoshin Shoji Co Ltd Photocatalyst fixing adhesive tape
JP2001106633A (en) * 1999-08-02 2001-04-17 Kenichi Yamanaka Utilization of titanium oxide as drug or substance analogous to drug
JP2001114693A (en) * 1999-08-09 2001-04-24 Kenichi Yamanaka Therapeutic article using titanium oxide

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI613990B (en) * 2016-12-08 2018-02-11 南臺科技大學 Hemostasis method
TWI618525B (en) * 2016-12-13 2018-03-21 奇美醫療財團法人奇美醫院 Femoral artery compression hemostasis device
CN108720885A (en) * 2017-04-20 2018-11-02 南台科技大学 Hemostasis

Similar Documents

Publication Publication Date Title
AR040305A1 (en) HEMOSTATIC BANDING FOR WOUNDS CONTAINING A MODIFIED POLYACARIDE WITH ALDEHYDE AND HEMOSTATIC AGENTS
CA2400228A1 (en) Medical dressings with multiple adhesives and methods of manufacturing
ATE423559T1 (en) COMBINATION THERAPY USING GLUCOSE ABSORPTION INHIBITORS AND PPAR MODULATORS
PE34197A1 (en) ABSORBENT PRODUCT
ES2062355T3 (en) PHARMACEUTICAL COMPOSITION INCLUDING LORATADINE, IBUPROPHEN AND PSEUDOEFEDRINE.
ATE232393T1 (en) USE OF SUBSTANCES WITH OXYTOCIN ACTION FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR WOUND HEALING
NO922809L (en) PROCEDURE FOR MANUFACTURING HUMANT THROMBINE CONCENTRATE FOR THERAPEUTIC USE
CA2460152A1 (en) Cellulose material with improved absorbency
WO2004045756A3 (en) Apparatus and method for photocatalytic purification and disinfection of fluids
EP0712635A4 (en) Medical polymer gel
ES2084390T3 (en) VARIOUS LAYER CONTROLLED RELEASE TABLETS CONTAINING BOTH NAPROXEN AND SODIUM NAPROXEN SALT.
BRPI0417955A (en) ultrasonic bonding and embossing of an absorbent product
DE69941996D1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN EMERGENCY TREATMENTS AND ITS MANUFACTURING PROCESS
DE3689943T2 (en) Degraded tissue plasminogen activator species, pharmaceutical preparation, and method of making the same.
AR015933A1 (en) ENAMEL FOR ONE WITH ANTIPSORIASIC ACTIVITY AND PROCEDURE FOR PREPARATION
DE60203929D1 (en) TREATMENT PROCEDURE AND PHARMACEUTICAL COMPOSITION FOR EMERGENCY CONSUMER PREVENTION
Patri et al. An in vitro spectrophotometric analysis of the penetration of bleaching agent into the pulp chamber of intact and restored teeth
DE69902234D1 (en) MATRIX PROTEIN COMPOSITIONS FOR Wounds Healing
IL109157A0 (en) Two component fibrin glue
BR8907817A (en) PROCESS TO KILL MAMMAL TUMOR CELLS, PHARMACEUTICAL COMPOSITION FOR USE IN THE PROCESS, SPECIFIC ENZYMATIC CONVERSION INHIBITOR, PROCESS TO ELEVATE THE PROTOPORPHYRIN IX CONTENT AND PROCESS TO DETECT OR LOCATE CELLARS AND MULTIPLES IN TOMOROS AND TOMOROS TOMOROS E TOMOROS E TOMOS
CY1109726T1 (en) Core core disc
WO2004030703A3 (en) Irradiated absorbent materials
WO2003015801A1 (en) Hemostatic material, complex hemostatic material and method of hemostasis
Nascimento et al. Effect of sodium ascorbate on bond strength and metalloproteinases activity in bleached dentin
DE69633396D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ACTIVIN STIMULATOR

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP